US health panel ditches guidance to give hepatitis B vaccine to newborns

AI Summary
In December 2025, the Advisory Committee on Immunization Practices (ACIP), a US government vaccine panel, voted to rescind its recommendation that all newborns receive the hepatitis B vaccine. The new guidance advises parents with no history of hepatitis B to consult their healthcare provider about vaccinating their infants, while still recommending it for children of mothers with the virus. Medical experts and pharmaceutical companies have criticized the decision, citing concerns that it could lead to lower vaccination rates and increased hepatitis B infections. The change, considered a major shift under Secretary of Health and Human Services Robert F Kennedy Jr, has sparked controversy, with some experts questioning the ACIP's reliance on evidence regarding vaccine efficacy and safety. Hepatitis B is a virus that can cause chronic liver problems, with over a million deaths linked to it worldwide in 2022.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).
Topic Connections
Explore how the topics in this article connect to other news stories